Victory Capital Management
RLAY icon

Victory Capital Management’s Relay Therapeutics RLAY Stock Holding History

Victory Capital Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
83,771
+3,777
+5% +$54.8K ﹤0.01% 1708
2026
Q1 		$796K Buy
79,994
+64,978
+433% +$581K ﹤0.01% 1923
2025
Q4 		$127K Buy
15,016
+24
+0.2% +$171 ﹤0.01% 2255
2025
Q3 		$78.3K Sell
14,992
-422
-3% -$1.61K ﹤0.01% 2316
2025
Q2 		$53.3K Buy
15,414
+16
+0.1% +$48 ﹤0.01% 2374
2025
Q1 		$40.3K Buy
15,398
+151
+1% +$592 ﹤0.01% 2384
2024
Q4 		$62.8K Sell
15,247
-58,639
-79% -$319K ﹤0.01% 2369
2024
Q3 		$523K Sell
73,886
-2,653
-3% -$19.8K ﹤0.01% 1995
2024
Q2 		$499K Buy
76,539
+7,680
+11% +$52.5K ﹤0.01% 1977
2024
Q1 		$572K Buy
68,859
+57,392
+500% +$560K ﹤0.01% 1939
2023
Q4 		$126K Buy
+11,467
New +$96.8K ﹤0.01% 2311
2023
Q1 		– Sell
-45,560
Closed -$681K – 2677
2022
Q4 		$681K Sell
45,560
-21,570
-32% -$413K ﹤0.01% 1907
2022
Q3 		$1.5M Sell
67,130
-1,660
-2% -$36.4K ﹤0.01% 1543
2022
Q2 		$1.15M Buy
68,790
+59,600
+649% +$1.28M ﹤0.01% 1678
2022
Q1 		$219K Sell
9,190
-556
-6% -$13.5K ﹤0.01% 2391
2021
Q4 		$299K Buy
9,746
+1,403
+17% +$44.3K ﹤0.01% 2384
2021
Q3 		$263K Sell
8,343
-776
-9% -$26.1K ﹤0.01% 2426
2021
Q2 		$334K Buy
9,119
+1,955
+27% +$64.4K ﹤0.01% 2381
2021
Q1 		$248K Sell
7,164
-878
-11% -$38.1K ﹤0.01% 2466
2020
Q4 		$334K Buy
+8,042
New +$364K ﹤0.01% 2246

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Victory Capital Management's RLAY Position: Q2 2026 in Review

Victory Capital Management increased its Relay Therapeutics (RLAY) stake by 4.7% in Q2 2026, buying an estimated $54.8K and bringing the position to 83,771 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

Victory Capital Management first reported a position in RLAY in Q4 2020 and has held it in 20 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Victory Capital Management held 83,771 shares of Relay Therapeutics worth $1.57M as of Q2 2026.
  • Victory Capital Management bought 3,777 Relay Therapeutics shares in Q2 2026, an estimated $54.8K.
  • Relay Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1708 holding.
  • Victory Capital Management first reported a position in Relay Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.